secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2026-08-11T20:07:42+00:00
Accession:  0001528287-26-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace Q2 revenue $22.8M (+17% YoY); raises FY26 revenue guidance
--------------------------------------------------------------------

- Q2 2026 RNS revenue $22.5M, up 21.3% YoY; total revenue $22.8M vs $19.5M in Q2 2025.
- GAAP net loss narrowed to ($6.2)M from ($10.0)M YoY; Adjusted EBITDA loss improved to ($2.8)M from ($4.9)M.
- FY26 revenue guidance raised to $99.5M-$101.5M (from $99M-$101M); Adjusted EBITDA guided to ($7.5)M-($8.5)M.
- Launched ECoG Assistant AI decision-support tool; NAUTILUS 18-month data showed 77% median GTC seizure reduction.
- Cash $51.9M at June 30, 2026; DIXI product operations presented as discontinued; long-term borrowings $59.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/0001528287-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/npce-20260811.htm
  HTML page:      https://secwatch.observer/filing/0001528287-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer